Medscape Conference Coverage, based on selected sessions at the:

American Urological Association (AUA) 2008 Annual Meeting

May 17 - 22, 2008; Orlando, Florida

This activity is not sanctioned by, nor a part of, the American Urological Association. Conference news does not receive grant support and is produced independently.

Conference News

  • Civilian Bladder Trauma in Iraq

    Urologists share their experiences in the management of bladder injury in civilians with major abdominal trauma in Baghdad.
    Medscape Medical News, May 22, 2008
  • Vaccine for Metastatic Prostate Cancer

    A new adenovirus/PSA prostate cancer vaccine prolongs survival in patients with metastatic prostate cancer.
    Medscape Medical News, May 22, 2008
  • Secondary Benefits of Gastric Bypass Surgery

    Losing weight restores sexual function in morbidly obese men.
    Medscape Medical News, May 22, 2008
  • Drug Reduces Risk for Prostate Cancer

    Reanalysis of a landmark trial shows that finasteride reduces risks for most prostate cancers without boosting aggressive disease.
    Medscape Medical News, May 22, 2008
  • Pollutants Linked to Urologic Conditions in Infant Boys

    Maternal exposure to persistent organic pollutants is linked to urologic conditions in infant boys.
    Medscape Medical News, May 22, 2008
  • Lower-Urinary-Tract Symptoms and Falls

    Men with moderate or severe lower-urinary-tract symptoms are at a significantly greater risk for falls than men without such symptoms.
    Medscape Medical News, May 21, 2008
  • Adjuvant Radiation for Radical Prostatectomy

    Adjuvant radiation therapy increases the likelihood of cure in patients undergoing radical prostatectomy and should be offered to all high-risk postprostatectomy patients, according to the latest data from a significant, long-term study.
    Medscape Medical News, May 20, 2008
Disclaimer

The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the American Urological Association. These materials and the related activity are not sanctioned by the American Urological Association or the commercial supporter of the conference and do not constitute an official part of that conference.